{"id":1565,"date":"2016-04-27T11:11:32","date_gmt":"2016-04-27T09:11:32","guid":{"rendered":"http:\/\/www.seri-lugano.ch\/2016\/04\/27\/luce-uv-a-in-azione-contro-il-cheratocono\/"},"modified":"2016-04-27T11:11:32","modified_gmt":"2016-04-27T09:11:32","slug":"luce-uv-a-in-azione-contro-il-cheratocono-2","status":"publish","type":"post","link":"https:\/\/seri-lugano.ch\/en\/luce-uv-a-in-azione-contro-il-cheratocono-2\/","title":{"rendered":"UV-A LIGHT in action against keratoconus"},"content":{"rendered":"<p>Dr. Pinelli with Domenico Ielpo and his brother-in-lawKeratoconus is a pathology that markedly damages the quality of vision and tends to progress, but thanks to the treatment of transepithelial osmotic corneal cross-linking it is possible to stop its progression.<\/p>\n<div>\n<p>Keratoconus is a non-inflammatory condition of the cornea. The pathology consists in a progressive thinning of the corneal thickness which, in one or more points, from the normal dome shape passes to assume a cone shape.<\/p>\n<p>Keratoconus then induces an alteration of the cornea curvature resulting in a myopia associated with astigmatism that is badly corrected with glasses and contact lenses.<\/p>\n<\/div>\n<div>\n<p>In most cases it is a disorder that progresses until corneal transplantation is necessary. There is a non-surgical technique that allows stopping this process: the transepithelial osmotic corneal cross-linking, a non-invasive procedure able to fortify the cornea through luminous particles that interact with riboflavin to create new collagen bonds that strengthen it, slowing down its progressive alteration.<\/p>\n<p>Domenicantonio Ielpo, decided to rely on Dr. Pinelli to deal with keratoconus, was subjected to an absolutely painless treatment, which in a few minutes &#8211; through the combined action of ultraviolet light (UV-A rays) and ParaCel\u00ae, a molecule a riboflavin base developed by Dr. Pinelli and commercialized by the American multinational Avedro &#8211; has improved its lateral visual capacity.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Pinelli with Domenico Ielpo and his brother-in-lawKeratoconus is a pathology that markedly damages the quality of vision and tends to progress, but thanks to the treatment of transepithelial osmotic corneal cross-linking it is possible to stop its progression. Keratoconus is a non-inflammatory condition of the cornea. The pathology consists in a progressive thinning of [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1565","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/posts\/1565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/comments?post=1565"}],"version-history":[{"count":0,"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/posts\/1565\/revisions"}],"wp:attachment":[{"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/media?parent=1565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/categories?post=1565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seri-lugano.ch\/en\/wp-json\/wp\/v2\/tags?post=1565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}